+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ipsen Group - logo

Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases. The company offers drugs in urology – oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, Hexvix, Somatuline, NutropinAq and Dysport. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.

From
From
Extended Release Injectable Drugs - Product Thumbnail Image

Extended Release Injectable Drugs

  • Report
  • June 2023
  • 200 Pages
  • Global
From
From
From
Sarcoma Drugs Global Market Report 2024 - Product Thumbnail Image

Sarcoma Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Somatostatin Analogs Global Market Report 2024 - Product Thumbnail Image

Somatostatin Analogs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Constipation Treatment Global Market Report 2024 - Product Thumbnail Image

Constipation Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
Long-Acting Injectable Drugs - Product Thumbnail Image

Long-Acting Injectable Drugs

  • Report
  • December 2021
  • 170 Pages
  • Global
Loading Indicator